Lipocine Inc.
LPCN
$2.11
$0.052.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.57M | 2.00M | 1.98M | 4.32M | 4.21M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.57M | 2.00M | 1.98M | 4.32M | 4.21M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.57M | 2.00M | 1.98M | 4.32M | 4.21M |
| SG&A Expenses | 3.95M | 3.85M | 3.76M | 3.65M | 3.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.14M | 14.13M | 12.35M | 10.63M | 9.79M |
| Operating Income | -12.57M | -12.13M | -10.37M | -6.31M | -5.58M |
| Income Before Tax | -11.85M | -11.43M | -9.63M | -5.48M | -4.51M |
| Income Tax Expenses | 200.00 | 0.00 | 200.00 | 200.00 | 200.00 |
| Earnings from Continuing Operations | -11.85 | -11.43 | -9.63 | -5.48 | -4.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.85M | -11.43M | -9.63M | -5.48M | -4.51M |
| EBIT | -12.57M | -12.13M | -10.37M | -6.31M | -5.58M |
| EBITDA | -12.51M | -12.07M | -10.31M | -6.25M | -5.52M |
| EPS Basic | -1.87 | -1.96 | -1.77 | -1.02 | -0.84 |
| Normalized Basic EPS | -1.17 | -1.22 | -1.10 | -0.64 | -0.53 |
| EPS Diluted | -1.87 | -1.96 | -1.77 | -1.04 | -0.89 |
| Normalized Diluted EPS | -1.17 | -1.22 | -1.10 | -0.65 | -0.54 |
| Average Basic Shares Outstanding | 26.11M | 23.24M | 21.79M | 21.46M | 21.40M |
| Average Diluted Shares Outstanding | 26.11M | 23.24M | 21.79M | 21.80M | 21.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |